Thomas Henriksen - Ambu A/S Director, Employee Representative
| AMBFF Stock | USD 19.90 0.00 0.00% |
Director
Mr. Thomas Lykke Henriksen was Director, Employee Representative at AMBU AS since December 13, 2017. He is Senior HR Partner HRIS Manager. He also serves as Chairman of Viby Friskole. since 2017.
| Age | 50 |
| Tenure | 7 years |
| Phone | 45 72 25 20 00 |
| Web | https://www.ambu.com |
Ambu A/S Management Efficiency
The company has return on total asset (ROA) of 0.0141 % which means that it generated a profit of $0.0141 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0236 %, meaning that it generated $0.0236 on every $100 dollars invested by stockholders. Ambu A/S's management efficiency ratios could be used to measure how well Ambu A/S manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Melinda Litherland | Bio Rad Laboratories | 63 | |
| Susan Siegel | Nevro Corp | 60 | |
| Gregory Hinckley | Bio Rad Laboratories | 74 | |
| Tania DeVilliers | Bio Rad Laboratories | 50 | |
| David Davidar | Globus Medical | 54 | |
| Steve Zarrilli | Globus Medical | 57 | |
| James Tobin | Globus Medical | 75 | |
| Daniel Lemaitre | Globus Medical | 66 | |
| Michael DeMane | Nevro Corp | 63 | |
| Elizabeth Weatherman | Nevro Corp | 60 | |
| Ann Rhoads | Globus Medical | 55 | |
| Arnold Pinkston | Bio Rad Laboratories | 62 | |
| Alice Schwartz | Bio Rad Laboratories | 93 | |
| Brad Vale | Nevro Corp | 67 | |
| Jeffrey Edwards | Bio Rad Laboratories | 60 | |
| Shawn McCormick | Nevro Corp | 56 | |
| Kevin OBoyle | Nevro Corp | 62 | |
| Frank Fischer | Nevro Corp | 78 | |
Management Performance
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0141 |
Ambu A/S Leadership Team
Elected by the shareholders, the Ambu A/S's board of directors comprises two types of representatives: Ambu A/S inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ambu. The board's role is to monitor Ambu A/S's management team and ensure that shareholders' interests are well served. Ambu A/S's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ambu A/S's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Thomas Schmidt, Ex CFO | ||
| Henrik Ankjr, Ex Operations | ||
| Thomas Henriksen, Director, Employee Representative | ||
| Anders Williamsson, Managing Director | ||
| Steven Block, CEO USA | ||
| Nicolai Thomsen, Director Planning | ||
| Mikkel Wagner, Director Communications | ||
| Bassel Rifai, Chief VP | ||
| Mns Barsne, Ex Officer | ||
| Britt Jensen, Chief Officer |
Ambu Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Ambu A/S a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0236 | |||
| Return On Asset | 0.0141 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.03 % | |||
| Current Valuation | 3.73 B | |||
| Shares Outstanding | 219.75 M | |||
| Shares Owned By Insiders | 26.04 % | |||
| Shares Owned By Institutions | 36.20 % | |||
| Price To Earning | 64.15 X | |||
| Price To Book | 5.10 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Ambu Pink Sheet
Ambu A/S financial ratios help investors to determine whether Ambu Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ambu with respect to the benefits of owning Ambu A/S security.